Clinical Trial 23659

A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ARV-806 in Participants With KRAS G12D Mutated Advanced Solid Tumors

Disease Site: Any Site, Cervix, Colon, Corpus Uteri, Lung, Other Female Genital, Pancreas, Rectum

PI: Kim, Richard

Clinical Trial 23448

Disease Site: Anus, Any Site, Colon, Corpus Uteri, Lung, Other Digestive Organ, Pancreas, Rectum

PI: Biachi de Castria, Tiago

Clinical Trial 23599

Phase 1a/1b Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of BBO-11818 in Subjects with Advanced KRAS Mutant Cancers

Disease Site: Anus, Any Site, Colon, Lung, Pancreas, Rectum

PI: Haura, Eric

Clinical Trial 23585

Disease Site: Breast, Colon, Lung, Rectum

PI: Han, Heather

Clinical Trial 23132

A Phase 1 Study of SGN-EGFRd2 in Advanced Solid Tumors

Disease Site: Colon, Lung, Rectum

PI: Kim, Richard

Clinical Trial 23660

A Phase 1 Study of MOMA-341 as Monotherapy or Combination Therapy in Participants with Advanced or Metastatic Solid Tumors

Disease Site: Anus, Any Site, Colon, Corpus Uteri, Esophagus, Other Digestive Organ, Rectum

PI: Biachi de Castria, Tiago

Clinical Trial 23766

A First-in-Human Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of FID-022 as Monotherapy in Patients with Advanced Solid Tumors

Disease Site: Anus, Any Site, Breast, Colon, Esophagus, Larynx, Lip, Oral Cavity and Pharynx, Lung, Rectum, Small Intestine, Soft Tissue, Stomach

PI: Rabinowits, Guilherme

Clinical Trial 23549

Disease Site: Anus, Any Site, Breast, Cervix, Colon, Esophagus, Kaposi's sarcoma, Lip, Oral Cavity and Pharynx, Lung, Other Digestive Organ, Other Endocrine System, Other Urinary, Ovary, Rectum, Urinary Bladder

PI: Saltos, Andreas

Clinical Trial 21641

First-in-Human, Phase 1/1b, Open-label, Multicenter Study of Bifunctional EGFR/TGF_ Fusion Protein BCA101 Alone and in Combination with Pembrolizumab in Patients With EGFR-Driven Advanced Solid Tumors

Disease Site: Colon, Colorectal, Head & Neck, Larynx, Lip, Oral Cavity and Pharynx, Mouth, lip, Rectum

PI: Chung, Christine

Clinical Trial 23309

A Platform Study of RAS(ON) Inhibitors to Treat Patients with Gastrointestinal Solid tumor - SUB-A: Study of RMC-6236 in Combination with 5-flourouracil-based regimens in Patients with Unresectable or Metastatic Colorectal Cancer or Metastatic Pancreatic Ductal Adenocarcinoma, - SUB: Study of RMC-6236 in Combination with Cetuximab with or without mFOLFOX6 in Patients with Unresectable or Metastatic Colorectal Cancer or Metastatic Pancreatic Ductal Adenocarcinoma, - SUB-C: Study of RMC-6236 in Combination with Gemcitabine and Nab-paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma - SUB-D: Study of RMC-9805 with or without RMC-6236 in Combination with 5-flourouracil-based Therapies in Patients with RAS G12D-Mutant Unresectable or Metastatic Colorectal Cancer or Metastatic Pancreatic Ductal Adenocarcinoma - SUB-E: Study of RMC-9805 with or without RMC-6236 in Combination with Cetuximab-based Therapies in Patients with RAS G12D-Mutant Unresectable or Metastatic Colorectal Cancer or Metastatic Pancreatic Ductal Adenocarcinoma - SUB-F: Study of RMC-9805 With or Without RMC-6236 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with RAS G12D-Mutant Metastatic Pancreatic Ductal Adenocarcinoma

Disease Site: Colon, Colorectal, Rectum

PI: Biachi de Castria, Tiago

Clinical Trial 23480

Disease Site: Any Site, Breast, Esophagus, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, Urinary Bladder

PI: Kim, Richard

Clinical Trial 23553

Disease Site: Breast, Colon, Kidney, Lung, Rectum

PI: Kirtane, Kedar

Clinical Trials Search Results

17 Clinical Trials Found

Clinical Trials Search Results

Clinical Trial Search

17 Clinical Trials Found

Cambiar el idioma